Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 34901-34910 Newer>

The Motley Fool February 26, 2009 Rick Aristotle Munarriz	Hands Off, Steiner Steiner Leisure, the operator of cruise-ship spas, springs a leak in its latest quarter.
The Motley Fool February 26, 2009 Rich Smith	This Just In: Upgrades and Downgrades RBC Capital Markets initiates coverage on a vast range of medical device and drug makers. Read on for their buys, holds, and one sell.
The Motley Fool February 26, 2009 Christopher Barker	Tomorrow's Monster Move in Gold Swing traders (and especially shorts), beware. The multiyear bull market for gold remains in full effect.
The Motley Fool February 26, 2009 Anders Bylund	Microsoft Milks a Patent for All It's Worth Good R&D projects can still bring in licensing fees nearly a decade after the patents were granted, as TomTom is finding out for allegedly infringing on five of Microsoft's.
The Motley Fool February 26, 2009 Rich Smith	Salesforce.com Shuts Down the Skeptics Despite a great quarter and higher guidance from management, there's still reason for worry from the enterprise software provider.
The Motley Fool February 26, 2009 Brian Orelli	Big Blue Struts Its Stimulus Stuff The company announces that it had signed up four hospital groups in the U.S. to use its electronic medical records systems, after the stimulus bill contained $19 billion in grants and incentives to encourage doctors and hospitals to invest in electronic medical records.
The Motley Fool February 26, 2009 Rick Aristotle Munarriz	Why Didn't They See the Bullion Bubble? In the battle of asset classes, gold investors can laugh at the real-estate bust, global stock-market implosions, and the deterioration of bond and money market yields. Why aren't they cynical enough to stay away from the yellow stuff?
The Motley Fool February 26, 2009 Selena Maranjian	The Upside of Broker Fees The more frequently you trade, the more you'll pay your broker in commission fees. But many people may not know that factoring in the cost of those commissions can reduce your capital gains -- and cut the taxes you owe.
The Motley Fool February 26, 2009	3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: RadioShack... General Mills... Novartis...
The Motley Fool February 26, 2009 Brian Orelli	Ranbaxy Spoils It for Everyone The Food and Drug Administration claims that generic-drug maker Ranbaxy falsified data that it submitted to the agency. Other innocent drug companies may suffer from guilt by association.
<Older 34901-34910 Newer> Return to current articles.